Pathmanandavel S, Crumbaker M, Nguyen A, Yam AOW, et al. The prognostic value of post-treatment PSMA and FDG PET/CT in metastatic, castration-resistant prostate cancer treated with (177)LuPSMA-617 and NOX66 in a phase I/II trial (LuPIN). J Nucl Med 2022 Jun 23. pii: jnumed.122.264104. doi: 10.2967/jnumed.122.264104.
PMID: 35738906